| Related party balances and transactions |
Note
13 – Related party balances and transactions
Related
party balances
Other
receivable – related party
Schedule
of related party balances
| Name
of Related Party | |
Relationship | |
Nature | |
As
of June
30, 2026 | | |
As
of December
31, 2025 | |
| | |
| |
| |
| (Unaudited) | | |
| | |
| Alex Lai Kum Weng | |
Director of CKHP | |
Employee advance | |
$ | 8,570 | | |
$ | 8,625 | |
| Other receivable – related party | |
Director of CKHP | |
Employee advance | |
$ | 8,570 | | |
$ | 8,625 | |
Other
payables – related parties
| Name of Related
Party | |
Relationship | |
Nature | |
As
of June
30, 2026 | | |
As
of December
31, 2025 | |
| | |
| |
| |
(Unaudited) | | |
| |
| Kent Ridge Health Pte Ltd | |
Shareholders
of this entity are also the shareholders of the Company | |
Operating expense paid on behalf
of the Company | |
| 395,779 | | |
| 395,779 | |
| Meng Dong (James) Tan | |
Shareholder of the Company | |
Operating expense paid on behalf of the Company | |
| 2,181 | | |
| 2,181 | |
| Chong Yew Yen | |
Director of CKHP (resigned on July 31, 2024)
and shareholder of the Company | |
Operating expense paid on behalf of the Company | |
| 230 | | |
| 230 | |
| 8i Enterprises Pte Ltd (“8iEPL”)
(1) | |
Meng Dong (James) Tan who is the shareholder
of this entity is also a shareholder of the Company | |
Advisory services fee payable | |
| 360,000 | | |
| 315,000 | |
| 8i Digital services Pte Ltd (“8i Digital”) | |
Meng Dong (James) Tan who is a shareholders
of this entity is also a shareholder of the Company | |
Advisory services fee payable | |
| 21,948 | | |
| 21,948 | |
| Vivian Tay | |
Interim Chief Financial Officer of the Company | |
Operating expense paid on behalf of the Company | |
| - | | |
| 2,849 | |
| Alfred Lim | |
Chief Executive Officer,
an executive director and shareholder of the Company | |
Operating expense paid
on behalf of the Company | |
| 97,441 | | |
| 52,114 | |
| Total | |
| |
| |
$ | 877,579 | | |
$ | 790,101 | |
| Other
payables - related parties | |
| |
| |
$ | 877,579 | | |
$ | 790,101 | |
| (1) |
A
balance of $135,000
was converted into the Company’s
ordinary shares in March 2024. See Note 14. On March 16, 2024, the Company entered into a consultancy agreement (the “Consultancy
Agreement”) with 8i Enterprises Pte Ltd (“8iEPL”) for a term of 12 months to engage 8iEPL’s services in connection
with merger and acquisition advisory services, including advisory for acquisition of Fortress Cove and its subsidiaries which is
40%
owned by Meng Dong (James) Tan before the acquisition. As of June 30, 2026 and December 31, 2025, the Company had accrued $360,000
and $315,000
advisory service fee pertaining
to this Consultancy Agreement, respectively. |
EUDA
HEALTH HOLDINGS LIMITED AND SUBSIDIARIES
NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In
U.S. dollars, unless stated otherwise)
Short
term loans – related parties
See
Note 10 for details.
Convertible
notes – related parties
See
Note 10 for details.
Related
party transaction
Consulting
agreements with 8iEPL
On
March 16, 2024, the Company entered into a consultancy agreement (the “Consultancy Agreement”) with 8iEPL for a term of 12
months to engage 8iEPL’s services in connection with merger and acquisition advisory services. The Consultancy Agreement had been
renewed for an additional 12 months term in March 2025. As of June 30, 2026 and December 31, 2025, the Company had accrued $360,000 and
$315,000, respectively, in advisory service fees related to this Consultancy Agreement.
Revenue
- related parties
For
the six months ended June 30, 2026, the Company generated revenue from stem cell treatment services provided to related parties, including
Eric Lew, the Company’s Chairman, and Alfred Lim, the Company’s Chief Executive Officer, in the amounts of $26,550
and $NIL,
respectively. No
revenue from related parties was recognized for the six
months ended June 30, 2025.
|